Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

GoodRx Holdings Expects Q1 Adj Revenue of ~$195M-$198M Vs $192.91M Est, FY24 Adj Revenue of ~$800M Vs $790.53M Est

Author: Benzinga Newsdesk | February 29, 2024 07:09am

Guidance

For the first quarter and full year 2024, management is anticipating the following:

$ in millions

1Q 2024

1Q 2023

YoY Change

Revenue5

~$195-$198

$184.0

~6%-8%

Adjusted Revenue5

~$195-$198

$184.0

~6%-8%

Adjusted EBITDA Margin6

High twenty-percent range, potentially up to 30%

 

$ in millions

FY 2024

FY 2023

YoY Change

Revenue5

~$800

$750.3

~7%

Adjusted Revenue5

~$800

$760.3

~5%

Adjusted EBITDA6

~$250

Posted In: GDRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist